Cognition, Function, and Mood After COVID-19
Author Information
Author(s): Su Han, Yang Pei-Lin, Eaton Tammy L., Valley Thomas S., Langa Kenneth M., Ely E. Wesley, Thompson Hilaire J.
Primary Institution: Vanderbilt University
Hypothesis
What is the prevalence of post-COVID conditions (PCC) including cognitive impairment, functional limitation, and depressive symptoms, while controlling for individuals’ pre-illness status?
Conclusion
24% of COVID-19-positive individuals developed new impairments after infection, with significant increases in functional limitations and depressive symptoms compared to their pre-COVID baselines.
Supporting Evidence
- 24% of COVID-19-positive respondents exhibited new impairments after infection.
- Significant increases in functional limitations were observed post-COVID-19.
- Depressive symptoms were higher in COVID-19-positive individuals compared to those without COVID-19.
Takeaway
After getting COVID-19, some people have trouble thinking, doing daily tasks, or feeling happy. This study looked at how many people had these problems after their illness.
Methodology
A cross-sectional retrospective study using data from the Health and Retirement Study surveys conducted in 2018 and 2020.
Potential Biases
Potential underestimation of the impact of COVID-19 due to exclusion of participants unable to complete cognitive assessments.
Limitations
The study did not capture commonly reported symptoms like fatigue and may not have fully examined specific cognitive domains.
Participant Demographics
Average age of COVID-19 positive participants was 64, with 14% hospitalized; 60% were female.
Statistical Information
P-Value
p<0.001 for functional limitation, p=0.03 for depressive symptoms
Confidence Interval
[0.95, 0.97] for functional limitation, [1.04, 1.91] for depressive symptoms
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website